Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Section Content Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Safety

  • Print
  • Share
  • E-mail
-

Hycamtin (topotecan) Capsules

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – October 2011

 

Summary View

 

CONTRAINDICATIONS

  • ...should not be used in patients with severe bone marrow depression

 

WARNINGS AND PRECAUTIONS

Interstitial lung disease
  • interstitial lung disease..... added

 

ADVERSE REACTIONS

Postmarketing Experience
  • Respiratory, thoracic, and mediastinal disorders: Interstitial lung disease.
-
-